221 related articles for article (PubMed ID: 29422258)
1. Expression Analysis of miR-29b in Malignant and Benign Breast Tumors: A Promising Prognostic Biomarker for Invasive Ductal Carcinoma With a Possible Histotype-Related Expression Status.
Papachristopoulou G; Papadopoulos EI; Nonni A; Rassidakis GZ; Scorilas A
Clin Breast Cancer; 2018 Aug; 18(4):305-312.e3. PubMed ID: 29422258
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive clinicopathological evaluation of the differential expression of microRNA-331 in breast tumors and its diagnostic significance.
Papadopoulos EI; Papachristopoulou G; Ardavanis A; Scorilas A
Clin Biochem; 2018 Sep; 60():24-32. PubMed ID: 30063890
[TBL] [Abstract][Full Text] [Related]
3. MiR-4728-3p could act as a marker of HER2 status.
Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
[TBL] [Abstract][Full Text] [Related]
4. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
[TBL] [Abstract][Full Text] [Related]
5. Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.
Shubbar E; Kovács A; Hajizadeh S; Parris TZ; Nemes S; Gunnarsdóttir K; Einbeigi Z; Karlsson P; Helou K
BMC Cancer; 2013 Jan; 13():1. PubMed ID: 23282137
[TBL] [Abstract][Full Text] [Related]
6. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
Mar-Aguilar F; Luna-Aguirre CM; Moreno-Rocha JC; Araiza-Chávez J; Trevino V; Rodríguez-Padilla C; Reséndez-Pérez D
Asia Pac J Clin Oncol; 2013 Mar; 9(1):53-9. PubMed ID: 22898264
[TBL] [Abstract][Full Text] [Related]
8. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
Shao B; Wang X; Zhang L; Li D; Liu X; Song G; Cao H; Zhu J; Li H
Technol Cancer Res Treat; 2019 Jan; 18():1533033819828709. PubMed ID: 30786836
[TBL] [Abstract][Full Text] [Related]
9. Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.
Dai H; Gallagher D; Schmitt S; Pessetto ZY; Fan F; Godwin AK; Tawfik O
Hum Pathol; 2017 Mar; 61():68-77. PubMed ID: 27864119
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer: Role of IGF-1 and IGFBP-3 expression in prognostication.
Raval A; Trivedi S
Indian J Exp Biol; 2016 Oct; 54(10):619-629. PubMed ID: 30084561
[TBL] [Abstract][Full Text] [Related]
11. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA-based screening tool for breast cancer.
Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer.
Yousef GM; Scorilas A; Nakamura T; Ellatif MA; Ponzone R; Biglia N; Maggiorotto F; Roagna R; Sismondi P; Diamandis EP
Breast Cancer Res Treat; 2003 Mar; 78(2):149-58. PubMed ID: 12725415
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients.
He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G
Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408
[TBL] [Abstract][Full Text] [Related]
15. The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast.
Narbe U; Sjöström M; Forsare C; Bendahl PO; Alkner S; Leeb-Lundberg LMF; Lövgren K; Rydén L; Ingvar C; Fernö M
Breast Cancer Res Treat; 2019 Jun; 175(2):305-316. PubMed ID: 30796653
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients.
Tong D; Heinze G; Pils D; Wolf A; Singer CF; Concin N; Hofstetter G; Schiebel I; Rudas M; Zeillinger R
BMC Cancer; 2010 Dec; 10():682. PubMed ID: 21159173
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival.
Li Y; Hong F; Yu Z
J Int Med Res; 2013 Jun; 41(3):596-602. PubMed ID: 23696595
[TBL] [Abstract][Full Text] [Related]
18. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
20. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
